Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Current Assets (2016 - 2025)

Haemonetics (HAE) has 16 years of Current Assets data on record, last reported at $943.7 million in Q4 2025.

  • For Q4 2025, Current Assets fell 6.18% year-over-year to $943.7 million; the TTM value through Dec 2025 reached $943.7 million, down 6.18%, while the annual FY2025 figure was $935.0 million, 21.6% up from the prior year.
  • Current Assets reached $943.7 million in Q4 2025 per HAE's latest filing, up from $899.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.0 billion in Q4 2024 and bottomed at $684.4 million in Q3 2021.
  • Average Current Assets over 5 years is $813.8 million, with a median of $769.3 million recorded in 2023.
  • Peak YoY movement for Current Assets: fell 9.88% in 2021, then soared 31.49% in 2024.
  • A 5-year view of Current Assets shows it stood at $699.2 million in 2021, then increased by 1.01% to $706.3 million in 2022, then rose by 8.31% to $765.0 million in 2023, then soared by 31.49% to $1.0 billion in 2024, then dropped by 6.18% to $943.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $943.7 million in Q4 2025, $899.7 million in Q3 2025, and $913.2 million in Q2 2025.